Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (593906)	11/22/2010 8:04:15 AM
From: Brumar89	Respond to of 1583386

That sounds pretty good.

To: Tenchusatsu who wrote (593906)	11/22/2010 12:07:28 PM
From: bentway	Respond to of 1583386

US Approves 2nd Human Trial of Stem Cells MASS. COMPANY WILL TRY TO TREAT PROGRESSIVE BLINDNESS By Matt Cantor, Newser Staff Posted Nov 22, 2010 7:37 AM CST (NEWSER) – The FDA has approved the second stem-cell trial on humans: Advanced Cell Technology will test the effects of stem-cell treatments on 12 patients with Stargardt’s macular dystrophy, a disease that causes progressive blindness, Reuters reports. The currently untreatable disease causes degeneration of eye tissue beginning as early as age 10. With stem cells, “we can generate a virtually unlimited supply” of healthy eye tissue cells, said the chief medical officer at the Massachusetts lab. The trial could start "as soon as two to three months" from now, he added. Click here for more on the first approved stem cell trial.